VAXIMM Appoints Thomas D. Szucs, MD, as Chairman of the Board

VAXIMM Appoints Thomas D. Szucs, MD, as Chairman of the Board VAXIMM AG, a Swiss/German biotech company focused on developing oral T-cell immunotherapies, today announced the appointment of Thomas D. Szucs, MD, as Chairman of the Supervisory Board. He succeeds Thomas...